Is cell-free fetal DNA testing a safe option for women in a high-risk population after combined first-trimester testing?-Reference-Cited by-同舟云学术

Is cell-free fetal DNA testing a safe option for women in a high-risk population after combined first-trimester testing?

Published:2022-04 Issue:4 Volume:51 Page:102329
ISSN:2468-7847
Container-title:Journal of Gynecology Obstetrics and Human Reproduction
language:en
Short-container-title:Journal of Gynecology Obstetrics and Human Reproduction

Author:

Dap Matthieu,Caffin Lucie,Perdriolle-Galet Estelle,Bonnet Céline,Morel Olivier

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference24 articles.

1. Haute Autorité de Santé. Décision n° 2018.0243/DC/SCI/SEESP du 19 décembre 2018 du collège de la Haute Autorité de santé portant adoption d'un document d'information relatif au dépistage de la trisomie 21 et de sa méthode d’élaboration.

2. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis;Taylor-Phillips;BMJ Open,2016

3. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population—a systematic review and meta-analysis;Iwarsson;Acta Obstet Gynecol Scand,2017

4. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis;Gil;Ultrasound Obstet Gynecol,2015

5. Lower detectability of non-invasive prenatal testing compared to prenatal diagnosis in high-risk pregnant women;Wang;Ann Transl Med,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The implementation and impact of non-invasive prenatal testing (NIPT) for Down’s syndrome into antenatal screening programmes: A systematic review and meta-analysis;PLOS ONE;2024-05-16

2. The method for termination of mid-trimester pregnancy with placenta previa: A case study;Medicine;2022-08-05